Trial Profile
A study comparing dabigatran with warfarin in persistent and long-acting atrial fibrillation patients who were undergoing electrical cardioversion
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Apr 2015
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Warfarin
- Indications Embolism and thrombosis; Stroke
- Focus Therapeutic Use
- 20 Apr 2015 New trial record